|
|
This page has resources for the "seasoned survivors" - those men who have been treated for prostate cancer and are concerned about their ongoing health issues. Osteonecrosis of the Jaw (ONJ)Bisphosphonates such as Fosomax, Aredia, or Zometa are a class of drug which is used to treat prostate cancer patients. Initially these drugs were used to treat or prevent osteoporosis, the weakening of bones due to hormone therapy. More recently it has been discovered that bisphosphonates also have some usefulness in preventing bone metastases, due to their chemical effect on bone tissue, Recent experiences of patients treated with bisphosphonates have shown that there is a significant risk of a condition known as Osteonecrosis of the Jaw, or ONJ. This condition occurs when jaw bone of a patient receiving bisphosphonate treatment is exposed to bacteria as a result of some traumatic event such as a tooth extraction or root canal. A patient suffering from ONJ may not initially have any symptoms, but as time goes on, there is loss of bone tissue and disfigurement. For further information see the ONJ Website. Also see this article on Medscape.com. Community InvolvementOne of the things that we as prostate cancer survivors may
do to help others is to speak out on the subject of prostate cancer in our
community. Many men and their loved ones are not aware of the dangers presented
by prostate cancer, and of how easily it may be diagnosed at a very early stage.
|